Sign in
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022
Journal article   Peer reviewed

Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022

Nathaniel M Lewis, Nancy Murray, Katherine Adams, Diya Surie, Manjusha Gaglani, Adit A Ginde, Tresa McNeal, Shekhar Ghamande, David J Douin, H Keipp Talbot, …
Open forum infectious diseases, Vol.10(1), p.ofac698
2023-01-01
PMID: 36695662

Abstract

Major
Although relative vaccine effectiveness can be a useful measure to understand incremental benefit of a vaccine booster regimen compared with a primary series alone, absolute vaccine effectiveness estimates are needed to fully understand their benefit.
url
https://doi.org/10.1093/ofid/ofac698View
Published (Version of record) Open

Details

Logo image